Article Text

Download PDFPDF
O-76 First results from the action study
  1. Ida J Korfage1,
  2. CA Christensen2,
  3. Judith AC Rietjens1,
  4. AT Johnsen2,
  5. M Groenvold2 and
  6. Agnes van der Heide1
  7. On behalf of the ACTION consortium
  1. 1Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands
  2. 2Department of Public Health, University of Copenhagen, and Department of Palliative Medicine, Bispebjerg Hospital, Denmark


ACTION is a phase III multicenter cluster randomised controlled trial, in which 22 hospitals in Belgium, Denmark, Italy, the Netherlands, Slovenia, and the United Kingdom are randomised. In the intervention sites, patients are offered interviews with a trained facilitator, following the Respecting Choices ACP program. In the control sites, patients receive care as usual. In total, 1360 patients will be included. All participating patients will be asked to complete questionnaires at inclusion, and at 2.5 and 4.5 months post-inclusion. If a patient dies within a year after inclusion, a relative will be asked to complete a questionnaire on end-of-life care. Use of medical care will be assessed by checking medical files. Today we will present results of the feasibility study.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.